Mr. Moradi is a successful serial entrepreneur, and was named a Young Global Leader by the World Economic Forum in 2017. He has founded or been a principal in several nanotechnology and biomedical startups, and is a frequent invited speaker at major industry conferences around the world. Sensulin is developing a glucose-responsive once-a-day insulin for type I/II diabetes. It may make basal and prandial insulin obsolete, reduce the need for glucose monitoring, and turn the global insulin market on its head.